// App-Quantinova.ai

539P : Circulating tumor cells (CTCs), molecular alterations and their correlation with characteristics of patients (pts) with metastatic colorectal cancer (mCRC) treated in the Spanish TTD VISNÚ Program

Researchers

Presenter

  • J.Sastre

Principal Investigators

  • A.Martnez

  • I.Bando

  • I.Santamara

  • B.Bellosillo Paricio

  • S.Palanca

  • I.Peligros

  • B.Mediero

  • P.Llovet

  • V.Moreno

  • J.M.Viitez

  • P.Garcia-Alfonso

  • S.Gil

  • M.J.Ortiz Morales

  • M.A.Salud Salvia

  • G.Quintero

  • F.A.Gesto

  • E.Aranda Aguilar

  • E.Diaz Rubio

Medical Centers

  • Medical Oncology, Hospital Clinico Universitario San Carlos, CIBERONC Instituto de Salud Carlos III, Madrid, Spain

  • CTC Unit. Molecular Oncology Laboratory, Hospital Universitario Clínico San Carlos, Madrid. CIBERONC Instituto de Salud Carlos III. Instituto de Investigación Sanitaria San Carlos, Madrid, Spain, Madrid, Spain

  • Cardiology, Hospital Universitario Reina Sofía, Córdoba, Spain

  • Hospital Clinico Universitario San Carlos, Madrid, Spain

  • Hospital Universitario Central de Asturias, Oviedo, Spain

  • Molecular Biology Laboratory, Hospital del Mar, Barcelona, Spain

  • Molecular Biology Unit, Hospital Universitario y Politécnico La Fe, Valencia, Spain

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • CTC Unit. Molecular Oncology Laboratory, Hospital Universitario Clínico San Carlos, Madrid. CIBERONC Instituto de Salud Carlos III. Instituto de Investigación Sanitaria San Carlos, Madrid, Spain, Madrid, Spain

  • Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain

  • Medical Oncology Service, Hospital General Universitario Gregorio Maranon, Madrid, Spain

  • Medical Oncology, Hospital Universitario Regional y Virgen de la Victoria, Malaga, Spain

  • IMIBIC, Reina Sofia Hospital, University of Cordoba, CIBERONC, Instituto de Salud Carlos III/ Spain, Cordoba, Spain

  • Medical Oncology, Hospital de Lleida Arnau de Vilanova, Lérida, Spain

  • Cardiology Division, Hospital Lucus Augusti, Lugo, Spain

  • Hematology, Hospital Universitario Marques de Valdecilla, Santander, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved